Literature DB >> 15778928

Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure.

W Doehner1, S D Anker, I F Godsland.   

Abstract

BACKGROUND: Minimal model analysis of the intravenous glucose tolerance test (IVGTT) has been used successfully to demonstrate that patients with chronic heart failure (CHF) are insulin-resistant. Continuing experience in minimal model methodology has raised questions about how best to assign basal glucose concentrations during such analyses. METHODS AND
RESULTS: IVGTT data from randomly selected patients with CHF (n = 15) and controls (n = 15) were analysed using the minimal model, with the basal glucose concentration (G (b)) assigned the value of fasting plasma glucose concentration (G (fast)), or the value of plasma glucose concentration 180 minutes after the start of the IVGTT (G (180)). Insulin sensitivity (S (I)) was significantly higher with G (b) = G (fast), than with G (b) = G (180) (controls: 5.60 +/- 0.78 vs. 3.36 +/- 0.25/min/muU/ml x 10 (4), p = 0.0017; patients 4.19 +/- 0.54 vs. 2.36 +/- 0.15/min/microU/ml x 10 (4), p = 0.0004). At G (b) = G (fast), CHF patients showed a non-significant 25 % reduction in S (I) in comparison to controls (p = 0.15). In contrast, at G (b) = G (180), CHF patients showed a significant 30 % reduction of S (I) in comparison to controls (p = 0.0018). S (I) estimates derived at G (b) = G (fast) exhibited twice the variability of those estimated using G (b) = G (180) (coefficients of variation of S (I) in patients with CHF were 50.0 % and 24.8 %, respectively).
CONCLUSION: In studies of patients with CHF, greater precision and discriminatory power of insulin sensitivity estimates is obtained when the basal glucose concentration is taken as the plasma glucose concentration 180 minutes after the start of the IVGTT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778928     DOI: 10.1055/s-2005-861175

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Beta blockers and glucose metabolism in chronic heart failure: friend or foe?

Authors:  W Doehner; S D Anker
Journal:  Clin Res Cardiol       Date:  2008-01       Impact factor: 5.460

2.  Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure.

Authors:  Wolfram Doehner; Guelistan Turhan; Francisco Leyva; Mathias Rauchhaus; Anja Sandek; Ewa A Jankowska; Stephan von Haehling; Stefan D Anker
Journal:  ESC Heart Fail       Date:  2015-04-30

3.  Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS).

Authors:  Michael Knops; Claudia G Werner; Nadja Scherbakov; Jochen Fiebach; Jens P Dreier; Andreas Meisel; Peter U Heuschmann; Gerd J Jungehülsing; Stephan von Haehling; Ulrich Dirnagl; Stefan D Anker; Wolfram Doehner
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-03-13       Impact factor: 12.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.